Wyze Biotech

Company Drug

Wyze Biotech’s RJMty19 Injection Accepted for CDE Review for r/r B-Cell NHL

Fineline Cube Oct 30, 2023

Wyze Biotech Co., Ltd, a Guangdong-based developer of off-the-shelf universal DNT cell therapies, has announced...

Company Deals

Wyze Biotech Raises RMB59m to Advance DNT Cell Therapies

Fineline Cube Aug 17, 2022

Wyze Biotech Co., Ltd, a Guangdong-based developer of off-the-shelf universal DNT cell therapies, has reportedly...

Company Drug

Novo Nordisk semaglutide Alzheimer’s biomarkers fail primary endpoint

Company Medical Device

Acotec V-otter Microcatheter Secures NMPA Approval for TACE Procedures

Company Deals

Youjia-Bio Tongee-Medical Nucleic-Acid-Drug Partnership Targets Diabetes

Company Drug

Fosun-Pharma FXS0887 ATR-Inhibitor Gets NMPA Phase 1 Nod